When Azoles Cannot Be Used: The Clinical Effectiveness of Intermittent Liposomal Amphotericin Prophylaxis in Hematology Patients

BACKGROUND: Patients unable to take azoles are a neglected group lacking a standardized approach to antifungal prophylaxis. We evaluated the effectiveness and safety of intermittent liposomal amphotericin B (L-AMB) prophylaxis in a heterogenous group of hematology patients. METHODS: A retrospective...

Descripción completa

Detalles Bibliográficos
Autores principales: Batchelor, R, Thomas, C, Gardiner, B J, Lee, S J, Fleming, S, Wei, A, Coutsouvelis, J, Ananda-Rajah, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Major Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318248/
https://www.ncbi.nlm.nih.gov/pubmed/34337090
http://dx.doi.org/10.1093/ofid/ofab113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318248/
https://www.ncbi.nlm.nih.gov/pubmed/34337090
http://dx.doi.org/10.1093/ofid/ofab113

Ejemplares similares